Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
96,902,244
-
Share change
-
+5,843,407
-
Total reported value
-
$788,823,033
-
Put/Call ratio
-
27%
-
Price per share
-
$8.14
-
Number of holders
-
228
-
Value change
-
+$58,408,445
-
Number of buys
-
133
-
Number of sells
-
89
Institutional Holders of Xeris Biopharma Holdings, Inc. - COM (XERS) as of Q3 2025
As of 30 Sep 2025,
Xeris Biopharma Holdings, Inc. - COM (XERS) was held by
228 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
96,902,244 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, D. E. Shaw & Co., Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Qube Research & Technologies Ltd, MORGAN STANLEY, Nuveen, LLC, Driehaus Capital Management LLC, and Rosalind Advisors, Inc..
This page lists
228
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.